Bausch + Lomb Corp (BLCO) stock news · rev $5.10B
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
This BLCO news page leads with what Bausch + Lomb Corp filed — not a scraped headline mill.
No cached 8-K sentence for BLCO yet. We will not pad this page with generic market recap.
Latest reported BLCO revenue for 2025-12-31 was $5.10B. Net income was -$360.0M. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. BLCO currently screens at market cap $5.38B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BLCO stock page; for the tape open the quote page.
BLCO stock news FAQ
What are BLCO's latest revenue and net income?
Latest cached Bausch + Lomb Corp (BLCO) revenue for Dec 31, 2025 was $5.10B. Net income was -$360.0M. Statements: https://lician.com/financials/blco
How did BLCO revenue change from the prior cached period?
Cached Bausch + Lomb Corp (BLCO) revenue was up 6.5% from $4.79B (Dec 31, 2024) to $5.10B (Dec 31, 2025). Statements: https://lician.com/financials/blco
What is BLCO's market cap?
Bausch + Lomb Corp (BLCO) market cap is $5.38B on the latest cached fundamentals snapshot.
What kind of company is BLCO?
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
Where is BLCO stock news listed?
Cached stock news for Bausch + Lomb Corp (BLCO) is listed at https://lician.com/news/blco. Filings: https://lician.com/sec/blco
Not investment advice.